# Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)

> **NCT00099463** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10 (—)

## Conditions studied

- Healthy

## Interventions

- **PROCEDURE:** Blood Test
- **PROCEDURE:** Urine Test
- **PROCEDURE:** Physical Exam
- **DRUG:** Vaccine
- **DRUG:** VRC-SRSDNA015-00-VP

## Key facts

- **NCT ID:** NCT00099463
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-09
- **Primary completion:** —
- **Final completion:** 2007-08-22
- **Target enrollment:** 10 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099463, "Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00099463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*